David L. Goode

5.9k total citations · 2 hit papers
45 papers, 3.1k citations indexed

About

David L. Goode is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David L. Goode has authored 45 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 15 papers in Cancer Research and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David L. Goode's work include Cancer Genomics and Diagnostics (14 papers), Prostate Cancer Treatment and Research (8 papers) and Epigenetics and DNA Methylation (7 papers). David L. Goode is often cited by papers focused on Cancer Genomics and Diagnostics (14 papers), Prostate Cancer Treatment and Research (8 papers) and Epigenetics and DNA Methylation (7 papers). David L. Goode collaborates with scholars based in Australia, United States and Canada. David L. Goode's co-authors include Eugene Davydov, Gregory M. Cooper, Serafim Batzoglou, Arend Sidow, Marina Sirota, Anthony T. Papenfuss, B. Brett Finlay, Richard B. Pearson, Anna Trigos and Yuling Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

David L. Goode

44 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++

2010 1.1k citations Eugene Davydov, David L. Goode et al. PLoS Computational Biology profile →
Dissecting virulence: Systematic and functional analyses of a pathogenicity island

2004 511 citations Wanyin Deng, José L. Puente et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David L. Goode Australia	21	1.5k	1.2k	730	424	393	45	3.1k
Randal N. Johnston Canada	37	2.2k 1.5×	1.1k 1.0×	255 0.3×	520 1.2×	489 1.2×	105	4.1k
Thomas J. Albert United States	23	2.2k 1.4×	1.2k 1.0×	100 0.1×	374 0.9×	356 0.9×	29	3.4k
Anne L. Bishop United States	13	1.5k 1.0×	211 0.2×	499 0.7×	105 0.2×	197 0.5×	16	2.6k
Steve Hoffmann Germany	25	2.7k 1.7×	580 0.5×	116 0.2×	806 1.9×	127 0.3×	63	3.6k
Christian Muchardt France	43	6.2k 4.1×	789 0.7×	158 0.2×	691 1.6×	191 0.5×	78	7.2k
Patrick Lécine France	27	1.2k 0.8×	217 0.2×	104 0.1×	204 0.5×	416 1.1×	46	3.0k
Amy H. Bouton United States	35	2.1k 1.4×	610 0.5×	108 0.1×	305 0.7×	423 1.1×	60	3.8k
Ian Sudbery United Kingdom	21	2.7k 1.8×	535 0.5×	43 0.1×	677 1.6×	289 0.7×	31	3.7k
E. D. Sverdlov Russia	28	2.2k 1.5×	602 0.5×	61 0.1×	255 0.6×	109 0.3×	176	3.2k
Violaine Moreau France	28	1.7k 1.1×	444 0.4×	101 0.1×	297 0.7×	79 0.2×	59	3.2k

Countries citing papers authored by David L. Goode

Since Specialization

Citations

This map shows the geographic impact of David L. Goode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Goode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Goode more than expected).

Fields of papers citing papers by David L. Goode

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Goode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Goode. The network helps show where David L. Goode may publish in the future.

Co-authorship network of co-authors of David L. Goode

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Goode. A scholar is included among the top collaborators of David L. Goode based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Goode. David L. Goode is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jones, Jordan, Kate Jones, Stephen Q. Wong, et al.. (2024). Plasma ctDNA enables early detection of temozolomide resistance mutations in glioma. Neuro-Oncology Advances. 6(1). vdae041–vdae041. 8 indexed citations

Trigos, Anna, Yangyi Zhang, Richard W. Tothill, et al.. (2024). Disruption of metazoan gene regulatory networks in cancer alters the balance of co-expression between genes of unicellular and multicellular origins. Genome biology. 25(1). 110–110. 2 indexed citations

Tolmeijer, Sofie H., Emily Kwan, Anthony M. Joshua, et al.. (2024). 1616P Circulating tumour DNA (ctDNA) measurements and PET-imaging to evaluate response in a phase Ib trial of metastatic castration-resistant prostate cancer (mCRPC) treated with Lutetium-177-PSMA-617 (LuPSMA) plus pembrolizumab (PRINCE). Annals of Oncology. 35. S975–S976. 1 indexed citations

Yang, Tianpei, Maria Doyle, Angela Pizzolla, et al.. (2023). Spatial analysis with SPIAT and spaSim to characterize and simulate tissue microenvironments. Nature Communications. 14(1). 2697–2697. 38 indexed citations

AbuHammad, Shatha, et al.. (2023). PRMT5 and CDK4/6 inhibition result in distinctive patterns of alternative splicing in melanoma. PLoS ONE. 18(11). e0292278–e0292278. 1 indexed citations

Lawrence, Mitchell G., Laura H. Porter, David Pook, et al.. (2021). CX-5461 Sensitizes DNA Damage Repair–proficient Castrate-resistant Prostate Cancer to PARP Inhibition. Molecular Cancer Therapeutics. 20(11). 2140–2150. 17 indexed citations

Kusnadi, Eric, Anna Trigos, Carleen Cullinane, et al.. (2020). Reprogrammed mRNA translation drives resistance to therapeutic targeting of ribosome biogenesis. The EMBO Journal. 39(21). e105111–e105111. 28 indexed citations

Fettke, Heidi, Jason A. Steen, Edmond M. Kwan, et al.. (2020). Analytical Validation of an Error-Corrected Ultra-Sensitive Ctdna Next-Generation Sequencing Assay. BioTechniques. 69(2). 133–140. 5 indexed citations

Trigos, Anna, Richard B. Pearson, Anthony T. Papenfuss, & David L. Goode. (2019). Somatic mutations in early metazoan genes disrupt regulatory links between unicellular and multicellular genes in cancer. eLife. 8. 44 indexed citations

10.

Kader, Tanjina, David L. Goode, Stephen Q. Wong, et al.. (2016). Copy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissue. Genome Medicine. 8(1). 121–121. 34 indexed citations

11.

Li, Na, Ella R. Thompson, Simone M. Rowley, et al.. (2016). Reevaluation of RINT1 as a breast cancer predisposition gene. Breast Cancer Research and Treatment. 159(2). 385–392. 12 indexed citations

12.

Wong, Stephen H.K., David L. Goode, Masayuki Iwasaki, et al.. (2015). The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic Potential. Cancer Cell. 28(2). 198–209. 103 indexed citations

13.

Ryland, Georgina L., Maria Doyle, David L. Goode, et al.. (2015). Loss of heterozygosity: what is it good for?. BMC Medical Genomics. 8(1). 45–45. 67 indexed citations

14.

Li, Jason, Maria Doyle, Isaam Saeed, et al.. (2014). Bioinformatics Pipelines for Targeted Resequencing and Whole-Exome Sequencing of Human and Mouse Genomes: A Virtual Appliance Approach for Instant Deployment. PLoS ONE. 9(4). e95217–e95217. 18 indexed citations

15.

Davydov, Eugene, David L. Goode, Marina Sirota, et al.. (2010). Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++. PLoS Computational Biology. 6(12). e1001025–e1001025. 1068 indexed citations breakdown →

16.

Goode, David L., Gregory M. Cooper, Jeremy Schmutz, et al.. (2010). Evolutionary constraint facilitates interpretation of genetic variation in resequenced human genomes. Genome Research. 20(3). 301–310. 55 indexed citations

17.

Deng, Wanyin, José L. Puente, Samantha Gruenheid, et al.. (2004). Dissecting virulence: Systematic and functional analyses of a pathogenicity island. Proceedings of the National Academy of Sciences. 101(10). 3597–3602. 511 indexed citations breakdown →

18.

Hokamp, Karsten, Fiona Roche, Marc-Étienne Rousseau, et al.. (2004). ArrayPipe: a flexible processing pipeline for microarray data. Nucleic Acids Research. 32(Web Server). W457–W459. 67 indexed citations

19.

Meers, P.D. & David L. Goode. (1965). SALMONELLA TYPHI IN CORNED BEEF. The Lancet. 285(7382). 426–428. 9 indexed citations

20.

Meers, P.D. & David L. Goode. (1965). CHEMICAL AND PHYSICAL BEHAVIOUR OF COLLAGEN FIBRE IN ALKALINE SOLUTIONS. Journal of The Society of Leather Technologists and Chemists. 24(4). 140–144. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact